Contrast Volume Reduction During PCI With the Use of a New Assisting Software Package



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:2/17/2019
Start Date:December 15, 2017
End Date:August 1, 2019
Contact:Martine van Alfen
Email:Martine.van.alfen@philips.com
Phone:+1 (617) 735-0209

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Contrast Volume Reduction During Percutaneous Coronary Interventions With the Use of a New Assisting Software Package

The new software package is intended to assist the physician in imaging the coronaries during
percutaneous coronary interventions.

This study investigates the amount of contrast used during percutaneous coronary
interventions with the aid of the new software package.

The results of the study will be compared with control group data (before the new software
package was installed or after it was removed) to define a possible contrast reduction.


Inclusion Criteria:

- Subject undergoing a percutaneous coronary intervention.

- Subject 18 years of age or older, or of legal age to give informed consent per state
or national law.

Exclusion Criteria:

- Subject undergoing an emergency treatment

- Primary angioplasty for acute ST segment elevation myocardial infarction.

- Subject with contrast allergies

- Subject with severe kidney disease (e-GFR < 40 by Modification of Diet in Renal
Disease (MDRD)/Cockcroft Gault clearance formula and/or upon decision by investigator)

- Subject participates in a potentially confounding drug or device trial during the
course of the study.

- Prisoners, people who cannot legally give consent, pregnant women and breastfeeding
women.
We found this trial at
1
site
Columbia University Medical Center - NYPH
New York, New York 10032
Principal Investigator: Manish Parikh, MD
Phone: 212.342.3488
?
mi
from
New York, NY
Click here to add this to my saved trials